- Home
- ATOS vs OCFT Comparison
ATOS vs OCFT Comparison
Compare ATOS & OCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- OCFT
- Stock Information
- Founded
- ATOS 2009
- OCFT 2015
- Country
- ATOS United States
- OCFT China
- Employees
- ATOS 10
- OCFT N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- OCFT Computer Software: Programming Data Processing
- Sector
- ATOS Health Care
- OCFT Technology
- Exchange
- ATOS Nasdaq
- OCFT Nasdaq
- Market Cap
- ATOS 114.5M
- OCFT 102.5M
- IPO Year
- ATOS 2012
- OCFT 2019
- Fundamental
- Price
- ATOS $0.96
- OCFT $2.93
- Analyst Decision
- ATOS Strong Buy
- OCFT Strong Buy
- Analyst Count
- ATOS 3
- OCFT 1
- Target Price
- ATOS $7.00
- OCFT $7.00
- AVG Volume (30 Days)
- ATOS 826.7K
- OCFT 20.2K
- Earning Date
- ATOS 11-12-2024
- OCFT 03-17-2025
- Dividend Yield
- ATOS N/A
- OCFT N/A
- EPS Growth
- ATOS N/A
- OCFT N/A
- EPS
- ATOS N/A
- OCFT 0.00
- Revenue
- ATOS N/A
- OCFT $407,825,504.00
- Revenue This Year
- ATOS N/A
- OCFT N/A
- Revenue Next Year
- ATOS N/A
- OCFT N/A
- P/E Ratio
- ATOS N/A
- OCFT $27.72
- Revenue Growth
- ATOS N/A
- OCFT N/A
- 52 Week Low
- ATOS $0.77
- OCFT $0.87
- 52 Week High
- ATOS $2.31
- OCFT $4.98
- Technical
- Relative Strength Index (RSI)
- ATOS 39.54
- OCFT 58.95
- Support Level
- ATOS $0.81
- OCFT $2.41
- Resistance Level
- ATOS $0.94
- OCFT $2.96
- Average True Range (ATR)
- ATOS 0.05
- OCFT 0.13
- MACD
- ATOS 0.01
- OCFT 0.03
- Stochastic Oscillator
- ATOS 39.13
- OCFT 76.31
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.